Pricing
Login
Home
Charts
Search
Watchlist
Products

Ajanta Pharma Ltd

AJANTPHARM
₹3,317.70+1.45%20 Nov 2026
Reports
Pharma Formulations

Ajanta Pharma Ltd

AJANTPHARM
₹3,317.70
+1.45%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹41,458Cr
Close
Close Price
₹3,317.70
Industry
Industry
Pharma Formulations
PE
Price To Earnings
32.82
PS
Price To Sales
6.67
Revenue
Revenue
₹6,217Cr
Rev Gr TTM
Revenue Growth TTM
25.01%
PAT Gr TTM
PAT Growth TTM
29.70%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,1051,0541,1451,1871,1461,1701,3031,3541,3751,4221,6261,794
Growth YoY
Revenue Growth YoY%
13.719.512.115.43.711.013.814.119.921.524.832.5
Expenses
ExpensesCr
7917768158758258739511,0269931,0881,2021,247
Operating Profit
Operating ProfitCr
314278330311321297351328382333424548
OPM
OPM%
28.426.428.926.228.025.427.024.227.823.426.130.5
Other Income
Other IncomeCr
143626193018265925617137
Interest Expense
Interest ExpenseCr
221686535232
Depreciation
DepreciationCr
343434343640414344454548
PBT
PBTCr
291278322290307269331341359347447535
Tax
TaxCr
81757674754476818580113147
PAT
PATCr
210203246216233225255260274267334388
Growth YoY
PAT Growth YoY%
56.165.818.110.810.911.13.920.217.618.430.949.2
NPM
NPM%
19.019.221.518.220.319.319.619.219.918.820.621.6
EPS
EPS₹
16.716.119.517.318.618.020.420.821.921.426.831.1
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,1051,0541,1451,1871,1461,1701,3031,3541,3751,4221,6261,794
Growth YoY
Revenue Growth YoY%
13.719.512.115.43.711.013.814.119.921.524.832.5
Expenses
ExpensesCr
7917768158758258739511,0269931,0881,2021,247
Operating Profit
Operating ProfitCr
314278330311321297351328382333424548
OPM
OPM%
28.426.428.926.228.025.427.024.227.823.426.130.5
Other Income
Other IncomeCr
143626193018265925617137
Interest Expense
Interest ExpenseCr
221686535232
Depreciation
DepreciationCr
343434343640414344454548
PBT
PBTCr
291278322290307269331341359347447535
Tax
TaxCr
81757674754476818580113147
PAT
PATCr
210203246216233225255260274267334388
Growth YoY
PAT Growth YoY%
56.165.818.110.810.911.13.920.217.618.430.949.2
NPM
NPM%
19.019.221.518.220.319.319.619.219.918.820.621.6
EPS
EPS₹
16.716.119.517.318.618.020.420.821.921.426.831.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,7281,9832,1262,0552,5882,8903,3413,7434,2094,6485,4536,217
Growth
Revenue Growth%
17.214.87.2-3.325.911.715.612.012.410.417.325.0
Expenses
ExpensesCr
1,1471,2961,4671,4891,9051,8912,4122,9593,0373,3894,0584,530
Operating Profit
Operating ProfitCr
5816876585666839999297831,1721,2601,3951,687
OPM
OPM%
33.634.631.027.626.434.627.820.927.927.125.627.1
Other Income
Other IncomeCr
172424218826116998595172195
Interest Expense
Interest ExpenseCr
51011281067211613
Depreciation
DepreciationCr
4561607296116125131135144173181
PBT
PBTCr
5476486235146649009097451,1141,1891,3781,688
Tax
TaxCr
146141154127196246197157298269322425
PAT
PATCr
4015074693874686547135888169201,0561,263
Growth
PAT Growth%
29.626.3-7.5-17.420.939.89.0-17.538.812.814.729.7
NPM
NPM%
23.225.622.118.818.122.621.315.719.419.819.420.3
EPS
EPS₹
31.538.435.529.335.750.136.649.964.873.684.5101.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,7281,9832,1262,0552,5882,8903,3413,7434,2094,6485,4536,217
Growth
Revenue Growth%
17.214.87.2-3.325.911.715.612.012.410.417.325.0
Expenses
ExpensesCr
1,1471,2961,4671,4891,9051,8912,4122,9593,0373,3894,0584,530
Operating Profit
Operating ProfitCr
5816876585666839999297831,1721,2601,3951,687
OPM
OPM%
33.634.631.027.626.434.627.820.927.927.125.627.1
Other Income
Other IncomeCr
172424218826116998595172195
Interest Expense
Interest ExpenseCr
51011281067211613
Depreciation
DepreciationCr
4561607296116125131135144173181
PBT
PBTCr
5476486235146649009097451,1141,1891,3781,688
Tax
TaxCr
146141154127196246197157298269322425
PAT
PATCr
4015074693874686547135888169201,0561,263
Growth
PAT Growth%
29.626.3-7.5-17.420.939.89.0-17.538.812.814.729.7
NPM
NPM%
23.225.622.118.818.122.621.315.719.419.819.420.3
EPS
EPS₹
31.538.435.529.335.750.136.649.964.873.684.5101.1
Sales CAGR
1 Year17%
3 Years13%
5 Years14%
TTM25%
EBITDA CAGR
1 Year11%
3 Years21%
5 Years7%
TTM30%
PAT CAGR
1 Year15%
3 Years22%
5 Years10%
TTM30%
Avg. ROCE
1 Year29%
3 Years31%
5 Years28%
TTM34%
CFO / EBITDA
1 Year38%
3 Years65%
5 Years69%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
181818181817172525252525
Reserves
ReservesCr
1,1541,5502,0242,2282,5812,9783,2473,3633,5423,7654,5024,833
Current Liabilities
Current LiabilitiesCr
2712473463786066496471,1398969961,4161,343
Non Current Liabilities
Non Current LiabilitiesCr
38336173114134144152175229212224
Total Liabilities
Total LiabilitiesCr
1,4811,8482,4492,6963,3193,7794,0564,6794,6385,0156,1556,425
Current Assets
Current AssetsCr
7648511,2241,1801,6422,0282,2642,8342,7312,8433,7353,823
Non Current Assets
Non Current AssetsCr
7189971,2251,5161,6771,7511,7911,8451,9072,1722,4192,602
Total Assets
Total AssetsCr
1,4811,8482,4492,6963,3193,7794,0564,6794,6385,0156,1556,425
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
181818181817172525252525
Reserves
ReservesCr
1,1541,5502,0242,2282,5812,9783,2473,3633,5423,7654,5024,833
Current Liabilities
Current LiabilitiesCr
2712473463786066496471,1398969961,4161,343
Non Current Liabilities
Non Current LiabilitiesCr
38336173114134144152175229212224
Total Liabilities
Total LiabilitiesCr
1,4811,8482,4492,6963,3193,7794,0564,6794,6385,0156,1556,425
Current Assets
Current AssetsCr
7648511,2241,1801,6422,0282,2642,8342,7312,8433,7353,823
Non Current Assets
Non Current AssetsCr
7189971,2251,5161,6771,7511,7911,8451,9072,1722,4192,602
Total Assets
Total AssetsCr
1,4811,8482,4492,6963,3193,7794,0564,6794,6385,0156,1556,425

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3266092813754575765627927851,157529
Investing Cash Flow
Investing Cash FlowCr
-209-383-256-223-224-282-74-56065-377-429
Financing Cash Flow
Financing Cash FlowCr
-119-2020-147-129-318-460-108-1,051-733-168
Net Cash Flow
Net Cash FlowCr
-124254104-2428124-20147-68
Free Cash Flow
Free Cash FlowCr
3276122813754675895807937981,158535
CFO To PAT
CFO To PAT%
81.3120.260.096.897.788.178.8134.796.2125.750.1
CFO To EBITDA
CFO To EBITDA%
56.288.742.766.166.857.760.4101.167.091.937.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3266092813754575765627927851,157529
Investing Cash Flow
Investing Cash FlowCr
-209-383-256-223-224-282-74-56065-377-429
Financing Cash Flow
Financing Cash FlowCr
-119-2020-147-129-318-460-108-1,051-733-168
Net Cash Flow
Net Cash FlowCr
-124254104-2428124-20147-68
Free Cash Flow
Free Cash FlowCr
3276122813754675895807937981,158535
CFO To PAT
CFO To PAT%
81.3120.260.096.897.788.178.8134.796.2125.750.1
CFO To EBITDA
CFO To EBITDA%
56.288.742.766.166.857.760.4101.167.091.937.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
12,41315,49212,3738,99111,92215,51715,45315,49028,18132,70835,02641,458
Price To Earnings
Price To Earnings
30.030.726.523.425.623.921.826.034.635.733.332.8
Price To Sales
Price To Sales
7.17.85.84.44.65.44.64.16.77.06.46.7
Price To Book
Price To Book
10.59.96.14.04.65.24.84.57.98.77.88.5
EV To EBITDA
EV To EBITDA
21.422.418.615.817.315.416.419.424.025.925.224.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
70.673.173.074.368.372.068.465.269.171.272.872.8
OPM
OPM%
33.634.631.027.626.434.627.820.927.927.125.627.1
NPM
NPM%
23.225.622.118.818.122.621.315.719.419.819.420.3
ROCE
ROCE%
44.441.430.522.625.330.028.021.931.131.529.134.3
ROE
ROE%
34.332.323.017.218.021.821.817.422.924.323.326.0
ROA
ROA%
27.127.419.114.314.117.317.612.617.618.417.219.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
12,41315,49212,3738,99111,92215,51715,45315,49028,18132,70835,02641,458
Price To Earnings
Price To Earnings
30.030.726.523.425.623.921.826.034.635.733.332.8
Price To Sales
Price To Sales
7.17.85.84.44.65.44.64.16.77.06.46.7
Price To Book
Price To Book
10.59.96.14.04.65.24.84.57.98.77.88.5
EV To EBITDA
EV To EBITDA
21.422.418.615.817.315.416.419.424.025.925.224.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
70.673.173.074.368.372.068.465.269.171.272.872.8
OPM
OPM%
33.634.631.027.626.434.627.820.927.927.125.627.1
NPM
NPM%
23.225.622.118.818.122.621.315.719.419.819.420.3
ROCE
ROCE%
44.441.430.522.625.330.028.021.931.131.529.134.3
ROE
ROE%
34.332.323.017.218.021.821.817.422.924.323.326.0
ROA
ROA%
27.127.419.114.314.117.317.612.617.618.417.219.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr54,98146,77844,35141,45838,67735,49928,451
Close PriceClose₹3,331.901,843.802,337.803,317.702,408.902,184.401,718.70
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE44.4432.4640.5432.8253.2286.5587.07
Price To SalesPS7.774.464.336.679.329.4613.55
RevenueRevenueCr7,07210,47910,2346,2174,1483,7512,100
Revenue Growth TTMRev Gr TTM%21.9%12.0%21.1%25.0%5.9%25.7%46.3%
PAT Growth TTMPAT Gr TTM%56.4%72.8%33.3%29.7%7.6%894.1%89.4%
Market CapitalizationMkt CapCr54,98146,77844,35141,45838,67735,49928,451
Close PriceClose₹3,331.901,843.802,337.803,317.702,408.902,184.401,718.70
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE44.4432.4640.5432.8253.2286.5587.07
Price To SalesPS7.774.464.336.679.329.4613.55
RevenueRevenueCr7,07210,47910,2346,2174,1483,7512,100
Revenue Growth TTMRev Gr TTM%21.9%12.0%21.1%25.0%5.9%25.7%46.3%
PAT Growth TTMPAT Gr TTM%56.4%72.8%33.3%29.7%7.6%894.1%89.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Dec 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Dec 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews